stopwords, and 2-character and smaller words are excluded
Papers by T Hunter
Total: 1331, Nodes: 439, Word count: 3586, All words count: 5382
View: Overview. Sorted by LCS.
Page 1 of 7: [ 1 2 3 4 5 6 7 ]
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 1 | TYROSINE | 64 | 14.6 | 447 | 9924
|
| 2 | ROUS-SARCOMA | 18 | 4.1 | 366 | 4998
|
| 3 | VIRUS | 27 | 6.2 | 354 | 4793
|
| 4 | PHOSPHORYLATION | 72 | 16.4 | 311 | 8688
|
| 5 | PROTEIN | 84 | 19.1 | 222 | 10619
|
| 6 | KINASE | 78 | 17.8 | 202 | 11534
|
| 7 | PROTEINS | 28 | 6.4 | 200 | 3927
|
| 8 | INVITRO | 20 | 4.6 | 169 | 2419
|
| 9 | PROTEIN-KINASE | 21 | 4.8 | 157 | 8005
|
| 10 | TRANSFORMING | 16 | 3.6 | 154 | 3426
|
| 11 | RECEPTOR | 42 | 9.6 | 151 | 6652
|
| 12 | PROTEIN-TYROSINE | 41 | 9.3 | 140 | 7351
|
| 13 | CELLS | 30 | 6.8 | 135 | 2698
|
| 14 | GENE | 17 | 3.9 | 129 | 2167
|
| 15 | SRC | 7 | 1.6 | 124 | 813
|
| 16 | PHOSPHORYLATES | 8 | 1.8 | 122 | 3259
|
| 17 | ACTIVITY | 24 | 5.5 | 112 | 4949
|
| 18 | GROWTH-FACTOR | 12 | 2.7 | 110 | 3537
|
| 19 | CHARACTERIZATION | 19 | 4.3 | 107 | 1560
|
| 20 | EVIDENCE | 10 | 2.3 | 105 | 2418
|
| 21 | INVIVO | 9 | 2.1 | 105 | 1832
|
| 22 | KINASES | 29 | 6.6 | 101 | 6710
|
| 23 | EPIDERMAL | 14 | 3.2 | 100 | 2706
|
| 24 | CELLULAR | 10 | 2.3 | 96 | 1027
|
| 25 | HUMAN | 19 | 4.3 | 96 | 3938
|
| 26 | SUBSTRATE | 21 | 4.8 | 89 | 3369
|
| 27 | PROTEIN-KINASES | 14 | 3.2 | 81 | 3728
|
| 28 | EXPRESSION | 20 | 4.6 | 78 | 1862
|
| 29 | GENE-PRODUCT | 3 | 0.7 | 76 | 2314
|
| 30 | MURINE | 23 | 5.2 | 76 | 888
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 31 | ANALYSIS | 11 | 2.5 | 73 | 1984
|
| 32 | REGULATION | 19 | 4.3 | 66 | 2809
|
| 33 | PROTEIN-PHOSPHORYLATION | 7 | 1.6 | 63 | 2436
|
| 34 | COMPARISON | 4 | 0.9 | 58 | 277
|
| 35 | SIMILAR | 3 | 0.7 | 56 | 1436
|
| 36 | SITE | 11 | 2.5 | 56 | 791
|
| 37 | ESSENTIAL | 6 | 1.4 | 55 | 1022
|
| 38 | CELL-CYCLE | 14 | 3.2 | 53 | 2148
|
| 39 | INDUCES | 6 | 1.4 | 50 | 2038
|
| 40 | IDENTIFICATION | 16 | 3.6 | 49 | 681
|
| 41 | PHOSPHOTYROSINE | 5 | 1.1 | 49 | 1422
|
| 42 | INDUCE | 4 | 0.9 | 48 | 404
|
| 43 | ADHESION | 14 | 3.2 | 47 | 2217
|
| 44 | CHANGES | 2 | 0.5 | 47 | 472
|
| 45 | CHICKEN-EMBRYO | 1 | 0.2 | 47 | 472
|
| 46 | FOCAL | 13 | 3.0 | 47 | 2211
|
| 47 | PRODUCTS | 3 | 0.7 | 47 | 406
|
| 48 | VIRUS-TRANSFORMED | 1 | 0.2 | 47 | 472
|
| 49 | GRB | 6 | 1.4 | 46 | 1658
|
| 50 | POLYOMA | 12 | 2.7 | 46 | 658
|
| 51 | SARCOMA-VIRUS | 11 | 2.5 | 45 | 441
|
| 52 | TRANSFORMED | 8 | 1.8 | 45 | 463
|
| 53 | PHOSPHORYLATED | 10 | 2.3 | 44 | 865
|
| 54 | PLATELET-DERIVED | 6 | 1.4 | 44 | 1782
|
| 55 | SIGNALING | 19 | 4.3 | 43 | 3375
|
| 56 | ACTIVATION | 25 | 5.7 | 42 | 2691
|
| 57 | CDK | 11 | 2.5 | 42 | 2686
|
| 58 | CELLULAR-TRANSFORMATION | 1 | 0.2 | 42 | 483
|
| 59 | SITES | 14 | 3.2 | 42 | 2555
|
| 60 | CYCLIN-A | 7 | 1.6 | 41 | 1811
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 61 | GROWTH | 16 | 3.6 | 41 | 1546
|
| 62 | PP60C-SRC | 8 | 1.8 | 41 | 1076
|
| 63 | SYNTHESIZED | 3 | 0.7 | 41 | 391
|
| 64 | TYR | 6 | 1.4 | 41 | 972
|
| 65 | DALTON | 5 | 1.1 | 39 | 362
|
| 66 | ACID | 3 | 0.7 | 38 | 1662
|
| 67 | DIFFERENT | 3 | 0.7 | 38 | 352
|
| 68 | TRANSLATION | 7 | 1.6 | 38 | 408
|
| 69 | CYTOPLASMIC | 8 | 1.8 | 37 | 1175
|
| 70 | NOVEL | 13 | 3.0 | 37 | 2251
|
| 71 | CELLULOSE | 2 | 0.5 | 36 | 1402
|
| 72 | CYCLIN | 9 | 2.1 | 36 | 1546
|
| 73 | DIMENSIONAL | 1 | 0.2 | 36 | 1315
|
| 74 | MAPPING | 2 | 0.5 | 36 | 1402
|
| 75 | PHOSPHOAMINO | 2 | 0.5 | 36 | 1402
|
| 76 | PHOSPHOPEPTIDE | 2 | 0.5 | 36 | 1402
|
| 77 | PLASMA-MEMBRANE | 5 | 1.1 | 36 | 670
|
| 78 | PLATES | 2 | 0.5 | 36 | 1402
|
| 79 | SEPARATION | 1 | 0.2 | 36 | 1315
|
| 80 | THIN-LAYER | 2 | 0.5 | 36 | 1402
|
| 81 | CELL | 24 | 5.5 | 35 | 1800
|
| 82 | CYCLIN-B | 6 | 1.4 | 35 | 1680
|
| 83 | EFFECTS | 2 | 0.5 | 35 | 413
|
| 84 | RAPID | 2 | 0.5 | 35 | 1525
|
| 85 | TRANSFORMATION | 8 | 1.8 | 35 | 382
|
| 86 | DETECTION | 4 | 0.9 | 34 | 1477
|
| 87 | DOMAINS | 6 | 1.4 | 34 | 4035
|
| 88 | CDNA | 7 | 1.6 | 33 | 1483
|
| 89 | KINASE-C | 4 | 0.9 | 33 | 1039
|
| 90 | T-ANTIGEN | 5 | 1.1 | 33 | 485
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 91 | THREONINE | 7 | 1.6 | 33 | 1061
|
| 92 | BINDING | 7 | 1.6 | 32 | 1494
|
| 93 | CATALYTIC | 3 | 0.7 | 32 | 4566
|
| 94 | MOLONEY | 7 | 1.6 | 32 | 390
|
| 95 | SIGNAL-TRANSDUCTION | 5 | 1.1 | 32 | 2079
|
| 96 | CLASSES | 1 | 0.2 | 31 | 166
|
| 97 | CYTOSKELETAL | 3 | 0.7 | 31 | 587
|
| 98 | HUMAN-TUMOR | 1 | 0.2 | 31 | 599
|
| 99 | PRESENT | 2 | 0.5 | 31 | 221
|
| 100 | RETROVIRUSES | 1 | 0.2 | 31 | 166
|
| 101 | TARGET | 3 | 0.7 | 31 | 746
|
| 102 | TYROSINES | 1 | 0.2 | 31 | 166
|
| 103 | PROTEIN-KINASE-C | 9 | 2.1 | 30 | 1884
|
| 104 | ADENOVIRUS | 5 | 1.1 | 28 | 741
|
| 105 | FAMILY | 4 | 0.9 | 28 | 3980
|
| 106 | QUANTIFICATION | 1 | 0.2 | 28 | 1277
|
| 107 | DOMAIN | 17 | 3.9 | 27 | 1005
|
| 108 | EGF | 3 | 0.7 | 27 | 1421
|
| 109 | MAJOR | 7 | 1.6 | 27 | 398
|
| 110 | SEQUENCE | 6 | 1.4 | 27 | 909
|
| 111 | INHIBITOR | 7 | 1.6 | 26 | 2035
|
| 112 | INTERACTION | 6 | 1.4 | 26 | 1242
|
| 113 | LOCALIZATION | 5 | 1.1 | 26 | 486
|
| 114 | VINCULIN | 1 | 0.2 | 26 | 540
|
| 115 | CLOSE | 3 | 0.7 | 25 | 588
|
| 116 | FACE | 3 | 0.7 | 25 | 588
|
| 117 | IMMUNOPRECIPITATES | 1 | 0.2 | 25 | 339
|
| 118 | PHOSPHORYLATING | 1 | 0.2 | 25 | 339
|
| 119 | RELATED | 5 | 1.1 | 25 | 1503
|
| 120 | STRUCTURAL | 8 | 1.8 | 25 | 856
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 121 | FACTOR | 12 | 2.7 | 24 | 1928
|
| 122 | FIBROBLASTS | 7 | 1.6 | 24 | 389
|
| 123 | PEPTIDE | 12 | 2.7 | 24 | 530
|
| 124 | TRANSCRIPTION | 11 | 2.5 | 24 | 3530
|
| 125 | DEDUCED | 2 | 0.5 | 23 | 3618
|
| 126 | INHIBITION | 8 | 1.8 | 23 | 455
|
| 127 | MESSENGER-RNA | 6 | 1.4 | 23 | 1012
|
| 128 | TARGETS | 3 | 0.7 | 23 | 173
|
| 129 | ABELSON | 2 | 0.5 | 22 | 134
|
| 130 | EXPRESSED | 5 | 1.1 | 22 | 364
|
| 131 | PHOSPHATASE | 11 | 2.5 | 22 | 397
|
| 132 | PRODUCT | 5 | 1.1 | 22 | 336
|
| 133 | CDC | 10 | 2.3 | 21 | 917
|
| 134 | ISOLATION | 4 | 0.9 | 21 | 978
|
| 135 | PRIMARY | 3 | 0.7 | 21 | 378
|
| 136 | CONSERVED | 1 | 0.2 | 20 | 3599
|
| 137 | CSF | 4 | 0.9 | 20 | 362
|
| 138 | DIFFERENTLY | 2 | 0.5 | 20 | 781
|
| 139 | FEATURES | 1 | 0.2 | 20 | 3599
|
| 140 | PATHWAY | 3 | 0.7 | 20 | 1125
|
| 141 | PHYLOGENY | 1 | 0.2 | 20 | 3599
|
| 142 | POLYOMA-VIRUS | 7 | 1.6 | 20 | 247
|
| 143 | BEHAVES | 1 | 0.2 | 19 | 658
|
| 144 | E1A-ASSOCIATED | 1 | 0.2 | 19 | 658
|
| 145 | FUNCTIONS | 3 | 0.7 | 19 | 251
|
| 146 | PROTEIN-P | 1 | 0.2 | 19 | 658
|
| 147 | TEMPERATURE-SENSITIVE | 5 | 1.1 | 19 | 182
|
| 148 | AMINO-ACIDS | 1 | 0.2 | 18 | 288
|
| 149 | CYCLIN-DEPENDENT | 5 | 1.1 | 18 | 428
|
| 150 | INFECTED | 6 | 1.4 | 18 | 197
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 151 | METABOLISM | 2 | 0.5 | 18 | 80
|
| 152 | RESIDUE | 3 | 0.7 | 18 | 571
|
| 153 | RNA | 6 | 1.4 | 18 | 119
|
| 154 | ROLE | 12 | 2.7 | 18 | 451
|
| 155 | SURROUNDING | 1 | 0.2 | 18 | 288
|
| 156 | IMMUNOFLUORESCENT | 2 | 0.5 | 17 | 195
|
| 157 | KINASE-ACTIVITY | 3 | 0.7 | 17 | 288
|
| 158 | P34-CDC | 1 | 0.2 | 17 | 735
|
| 159 | PHOSPHATASES | 9 | 2.1 | 17 | 2235
|
| 160 | PROTEIN-REGULATION | 1 | 0.2 | 17 | 735
|
| 161 | RAS | 3 | 0.7 | 17 | 1117
|
| 162 | REQUIRED | 8 | 1.8 | 17 | 370
|
| 163 | T-ANTIGENS | 5 | 1.1 | 17 | 203
|
| 164 | VIRUSES | 4 | 0.9 | 17 | 117
|
| 165 | CHICK | 1 | 0.2 | 16 | 63
|
| 166 | CONTAIN | 1 | 0.2 | 16 | 63
|
| 167 | DEPENDENT | 4 | 0.9 | 16 | 753
|
| 168 | DISCRETE | 1 | 0.2 | 16 | 63
|
| 169 | FUNCTION | 13 | 3.0 | 16 | 608
|
| 170 | IMPLICATIONS | 1 | 0.2 | 16 | 416
|
| 171 | INTEGRIN-MEDIATED | 2 | 0.5 | 16 | 999
|
| 172 | LIGASE | 9 | 2.1 | 16 | 981
|
| 173 | LINKED | 1 | 0.2 | 16 | 999
|
| 174 | LOCATIONS | 1 | 0.2 | 16 | 63
|
| 175 | MITOTIC | 8 | 1.8 | 16 | 497
|
| 176 | NUCLEAR | 9 | 2.1 | 16 | 1108
|
| 177 | RECOGNITION | 6 | 1.4 | 16 | 960
|
| 178 | VIRALLY | 1 | 0.2 | 16 | 63
|
| 179 | BINDING-SITE | 2 | 0.5 | 15 | 221
|
| 180 | C-KINASE | 2 | 0.5 | 15 | 700
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 181 | COMPLEX | 5 | 1.1 | 15 | 863
|
| 182 | COMPLEXES | 6 | 1.4 | 15 | 443
|
| 183 | E2-DEPENDENT | 2 | 0.5 | 15 | 586
|
| 184 | FACTOR-STIMULATED | 1 | 0.2 | 15 | 700
|
| 185 | MESSENGER-RNAS | 5 | 1.1 | 15 | 216
|
| 186 | PATHWAYS | 5 | 1.1 | 15 | 1256
|
| 187 | RECEPTOR-LIKE | 3 | 0.7 | 15 | 164
|
| 188 | REDUCES | 2 | 0.5 | 15 | 700
|
| 189 | SIGNAL | 6 | 1.4 | 15 | 916
|
| 190 | SYNTHETIC | 4 | 0.9 | 15 | 759
|
| 191 | TUMOR-ANTIGEN | 4 | 0.9 | 15 | 298
|
| 192 | ANTIBODIES | 5 | 1.1 | 14 | 229
|
| 193 | BASIS | 3 | 0.7 | 14 | 525
|
| 194 | COLONY-STIMULATING | 2 | 0.5 | 14 | 111
|
| 195 | DEPHOSPHORYLATION | 5 | 1.1 | 14 | 356
|
| 196 | DIFFERENCES | 1 | 0.2 | 14 | 87
|
| 197 | DNA-BINDING | 6 | 1.4 | 14 | 1717
|
| 198 | FACTOR-I | 2 | 0.5 | 14 | 111
|
| 199 | GLYCOLYTIC-ENZYMES | 1 | 0.2 | 14 | 190
|
| 200 | NATRIURETIC | 7 | 1.6 | 14 | 239
|
Page 1 of 7: [ 1 2 3 4 5 6 7 ]